Rapid Accurate Portable Tests (RAPT) Point-of-Care Testing (POCT) Reader
RAPT focuses on your lifelong health
Product Features:
- High stability and accuracy1
- Short testing time
- Easy-to-use color touch screen
- Lightweight and portable
- Less stringent storage requirements
- High capture efficiency of pathogenic nucleic acids
- Easy to insert PCR chip
- Small temperature differences in the process (<2%)
- Small Ct value error compared with ABI2 control group in clinical trials (<1.5%)
- Care must be taken to avoid collisions of the reader that can cause the displacement of optical monitoring to prevent from obtaining inaccurate Ct values. ↩︎
- Applied Biosystems StepOne™ Real-time PCR System ↩︎
Clinical Benefits：
- Early outbreak control
- Rapid separation of infected patients for next step treatment
- Easy sample preparation
- Shortened detection time; improve the testing rate of the public
- Reduced costs and healthcare resources
- Reduce the pressure on the central laboratory; decreased workflow of healthcare workers
- Benefited healthcare workers, patients, and hospitals/clinics/ pharmacies
Product Specifications：
| Storage Temperature | 15-30 oC |
| Sample Type | Saliva |
| Sample Prep Time | < 1 min |
| Sample Number | 1 |
| Medical Device Classification | Chip：Class 2 Analyzer：Class 1 |
| Weight | Chip：0.05 kg Analyzer：1.5 kg |
| Dimensions (W x D x H) | Chip：10 cm x 5 cm x 1 cm Analyzer：34 cm x 25 cm x 15 cm |
| Detection Time | 20 min |
| Limit of Detection (LoD) | 0.05 ng/mL |
| Power | 12 V DC/6.0 A |
Rapid Accurate Portable Tests (RAPT) SARS-CoV-2 Nucleic Acid Test Kit
Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by a novel human coronavirus, named SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) by the World Health Organization. COVID-19 and influenza are potentially fatal infections that result in significant worldwide morbidity and mortality. Rapid and accurate diagnosis of SARS-CoV-2 infections is important in individuals suspected of a respiratory infection. Using the RAPT SARS-CoV-2 Nucleic Acid Test Kit to detect the SARS-CoV-2 virus can help to inform time-critical medical decision-making, facilitate infection control efforts, promote efficient resourcing, optimize use of targeted therapies and antimicrobials, and reduce ancillary testing or procedures.
The RAPT SARS-CoV-2 Nucleic acid Test Kit is a rapid, single-use molecular diagnostic test kit for use on the RAPT system with an automated real-time RT-PCR assay for the qualitative detection of the novel coronavirus SARS-CoV-2 from self-collected saliva samples (under the guidance of medical professional, and/or healthcare providers) in individuals with known or suspected COVID-19 (Coronavirus Disease-2019).
RAPT Test Kit consists of:
- A single-use biochip
- Specimen preparation kit
- Reagent kit (sample vial, wash buffer vial and elution buffer vial)
- Instructions manual
- Waste disposal bag
Sample Preparation Steps：
